Compound 1216
Identifiers
- Canonical SMILES:
Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(cc2)C(=O)NCc2ccccc2)c1=O
- InChi:
InChI=1S/C29H21F3N6O2/c1-37-26-22(16-34-37)25-23(24(35-26)19-8-5-9-20(14-19)29(30,31)32)28(40)38(36-25)21-12-10-18(11-13-21)27(39)33-15-17-6-3-2-4-7-17/h2-14,16,36H,15H2,1H3,(H,33,39)
- InChiKey:
BIZLOZVLTWAKGE-UHFFFAOYSA-N
External links
![]() 12096165 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD80 / CD28 | 7.10 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 542.17 g/mol | |||
HBA | 8 | |||
HBD | 2 | |||
HBA + HBD | 10 | |||
AlogP | 5.79 | |||
TPSA | 92.15 | |||
RB | 6 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4917 | N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide | DB08349 | |
0.4917 | Riociguat | DB08931 | |
0.4847 | ATX-914 | DB12673 | |
0.4804 | 6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE | DB07218 | |
0.4760 | Vericiguat | DB15456 | |
0.4693 | Ispinesib | DB06188 | |
0.4609 | Merestinib | DB12381 | |
0.4609 | Decoglurant | DB11923 | |
0.4599 | Dilmapimod | DB12140 | |
0.4598 | Risdiplam | DB15305 | |
0.4520 | MK-0249 | DB11910 | |
0.4519 | Tepotinib | DB15133 | |
0.4483 | TAS-116 | DB14876 | |
0.4464 | 5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine | DB08534 | |
0.4458 | Filgotinib | DB14845 |